CEA blood test: what a high carcinoembryonic antigen level means
Carcinoembryonic antigen (CEA) · Tumor marker (ordered alone or with CA 19-9) · reported in ng/mL (equivalent to µg/L)
Carcinoembryonic antigen (CEA) is a protein made in large amounts by the developing fetus and in small amounts by adult gut, lung and breast tissue; a CEA blood test measures how much is circulating. In adults the normal level is under 3 ng/mL in non-smokers and under 5 ng/mL in smokers (labs differ, and some use 2.5 or 5 as the single cut-off). Its main use is in people who already have a diagnosis of colorectal cancer, where it is measured before surgery to help judge outlook and then every few months afterwards to detect a recurrence early.
CEA is not a cancer screening test. Only about a third of early-stage colorectal cancers raise it above 5 ng/mL, and a long list of ordinary conditions raise it mildly: smoking is the most common, followed by chronic lung disease, liver disease, pancreatitis, inflammatory bowel disease, diverticulitis and an underactive thyroid. A mildly raised CEA in someone with no cancer diagnosis is far more often one of these than a tumor, which is why guidelines advise against ordering it to look for cancer in healthy people.
The number itself carries information. Benign causes rarely push CEA above 10 ng/mL. Values above 10 raise genuine concern for cancer, values above 20 in someone with a known cancer usually mean it has spread, and a level that keeps rising on repeat testing is more telling than any single reading. The protein clears with a half-life of a few days, so after a tumor is completely removed CEA should return to normal within about four to six weeks.
CEA at a glance
- What it is: a glycoprotein shed by some cancers (colorectal most of all) and, in smaller amounts, by inflamed or damaged gut, lung and liver tissue.
- Normal: under 3 ng/mL in non-smokers, under 5 ng/mL in smokers; some labs use 2.5 or 5 ng/mL for everyone. Units are ng/mL (the same as µg/L).
- Not a screening test: a normal CEA does not rule cancer out, and a mildly raised one (3 to 10) is usually smoking or a benign condition.
- Over 10 ng/mL: cancer becomes much more likely and needs investigation; over 20 in a known cancer usually means metastatic disease.
- Main job: measured before colorectal cancer surgery (over 5 ng/mL is a worse-outlook marker) and every 3 to 6 months for 5 years afterwards to catch recurrence.
- Next step: a raised CEA with no diagnosis is repeated after 2 to 4 weeks with the benign causes reviewed; a persistent or rising result leads to a colonoscopy and CT scan.
Have your whole report? Paste it into the free Lab Explainer
Every marker explained in plain language, in context with the others, with questions to bring to your appointment. No account needed.
What CEA measures
CEA is a large sugar-coated protein that sits on the surface of cells lining the gut, where it helps cells stick to each other. Production is highest before birth and falls to a trickle in adulthood, but cancer cells that arise from gut-type lining often switch it back on and shed it into the bloodstream. Colorectal cancer does this most reliably; pancreatic, stomach, lung, breast, medullary thyroid and some ovarian cancers do it too. The liver clears CEA from the blood, which is one reason liver disease and liver metastases both raise it.
The lab measures CEA with an immunoassay (antibodies that bind the protein). Different manufacturers' assays give different absolute numbers, so results from two labs should not be compared directly and the same lab should be used for monitoring. Reports give ng/mL in the United States; µg/L is the identical number. Fasting is not required and there is no daily rhythm.
Interpretation depends entirely on why the test was ordered. In a healthy person the result is dominated by smoking and benign inflammation. In someone with colorectal cancer, the pre-treatment level and the trend after treatment are what matter: a rise of more than about 30 percent on two consecutive tests is a conventional signal of recurrence, usually several months before a scan shows it.
Normal range for CEA
Reference ranges vary between labs and by age, sex and pregnancy. Use the range printed on your own report.
| Group | Typical range (ng/mL (equivalent to µg/L)) | Notes |
|---|---|---|
| Non-smoking adults, normal | Below 3.0 ng/mL | Some labs use 2.5 or 5.0 ng/mL as the upper limit; use the cut-off on your report. Levels drift up slightly with age. |
| Smokers, normal | Below 5.0 ng/mL | Smoking roughly doubles CEA; about 1 in 5 smokers is above the non-smoker limit. Levels fall over the months after quitting. |
| Mild elevation | 3–10 ng/mL | Most often smoking, COPD, liver disease, pancreatitis, inflammatory bowel disease, diverticulitis or hypothyroidism. Repeat in 2 to 4 weeks before concluding anything. |
| Moderate elevation | 10–20 ng/mL | Benign disease rarely goes this high. Cancer of the colon, rectum, pancreas, stomach, lung or breast becomes a real possibility and needs a work-up. |
| Marked elevation | Above 20 ng/mL | In a known cancer, usually indicates spread to the liver or elsewhere. Values in the hundreds or thousands occur with widespread disease. |
| Before colorectal cancer surgery | Above 5 ng/mL is a poor-prognosis marker | Used in staging; a high pre-operative CEA that does not normalize within 4 to 6 weeks of surgery suggests residual disease. |
| After successful colorectal cancer treatment | Should be within the normal range | Checked every 3 to 6 months for 5 years; a confirmed rise of 30 percent or more above the baseline prompts imaging. |
High CEA
A high CEA means something is producing more of this protein than usual, and the size of the rise narrows down what. Between 3 and 10 ng/mL the most common explanations are smoking and benign inflammation of the lungs, liver, pancreas or bowel; this band is where almost everyone who gets an unexpected result falls, and most of them do not have cancer. Above 10 ng/mL the balance shifts: benign conditions rarely reach this level, so a colonoscopy and imaging of the chest, abdomen and pelvis are usually arranged.
In someone with a colorectal cancer diagnosis, the meaning is more specific. Before surgery, a CEA above 5 ng/mL is associated with a worse outlook at every stage and is sometimes treated as a reason for closer follow-up. After surgery with the tumor fully removed, the level should fall to normal within four to six weeks; if it does not, cancer has probably been left behind. During follow-up, a rising CEA is the earliest sign of recurrence in roughly two-thirds of cases, typically appearing three to six months before symptoms or a scan abnormality.
CEA is not a substitute for finding the tumor. About a quarter of colorectal cancers, and most early ones, never raise it, and poorly differentiated tumors in particular may produce none. A high value says that investigation is warranted; it does not say where the problem is or confirm that it is cancer, and a single raised result is always repeated before anything else is decided.
Common causes
Cigarette smoking
The most common cause of a mild rise. Smokers run levels roughly twice those of non-smokers, and about 19 percent of smokers exceed the non-smoker cut-off of 2.5 to 3 ng/mL. Values above 10 are unusual from smoking alone.
Colorectal cancer
The cancer CEA is most associated with. Around a third of stage I tumors, half of stage II and III, and three-quarters or more of metastatic cancers raise CEA above 5 ng/mL; levels track tumor bulk and liver involvement.
Other cancers
Pancreatic, stomach, esophageal, lung (especially adenocarcinoma), breast, medullary thyroid, mucinous ovarian, cervical and bladder cancers all shed CEA in a proportion of cases, usually at advanced stages.
Liver disease
Cirrhosis, chronic hepatitis and alcoholic liver disease raise CEA to 3 to 10 ng/mL because a damaged liver clears it more slowly. Liver metastases from any cancer raise it for the same reason plus tumor production.
Chronic lung disease
COPD, emphysema, chronic bronchitis and bronchiectasis commonly raise CEA mildly, compounding the effect of smoking; pneumonia can do the same temporarily.
Inflammatory and infectious bowel disease
Ulcerative colitis, Crohn's disease, diverticulitis and peptic ulcer disease each produce modest elevations, generally under 10 ng/mL, that rise and fall with disease activity.
Pancreatitis and gallbladder disease
Acute and chronic pancreatitis, cholecystitis and bile duct obstruction raise CEA; CA 19-9 rises alongside it in these conditions, which can confuse the picture.
Hypothyroidism
An underactive thyroid raises CEA, sometimes into the 5 to 10 range, and treatment with thyroid hormone brings it back down. Worth checking TSH when a raised CEA has no other explanation.
Benign breast disease and fibrocystic change
Can raise CEA slightly, which is one reason it is a poor breast cancer marker on its own.
Kidney failure and age
Reduced kidney clearance in chronic kidney disease, and aging itself, nudge CEA upward by a point or two.
Symptoms that can go with it
- Often none; CEA is usually raised long before any symptom in cancer recurrence, and benign causes produce the symptoms of the underlying condition rather than of CEA itself
- A change in bowel habit lasting more than a few weeks, narrower stools, or blood in or on the stool (colorectal cancer)
- Unexplained weight loss, loss of appetite, or iron-deficiency anemia with fatigue and breathlessness
- Persistent abdominal pain, bloating or a feeling of fullness; pain under the right ribs or jaundice with liver involvement
- A persistent cough, breathlessness or chest pain in smokers and people with lung disease
- Upper abdominal pain radiating to the back, pale stools or new diabetes (pancreatic causes)
- Tiredness, cold intolerance and weight gain with hypothyroidism
Normal or low CEA
There is no lower limit of concern for CEA, and a value reported as below the detection limit is simply normal. In a healthy non-smoker a result under 3 ng/mL is the expected finding. In someone being followed after colorectal cancer treatment, a CEA that has returned to normal and stays there is reassuring and is one of the main pieces of evidence that treatment has worked.
What a normal CEA cannot do is rule cancer out. Roughly a quarter of colorectal cancers never raise CEA, early-stage tumors usually do not, and some tumors lose the ability to make it as they become less differentiated. This is why a normal CEA never replaces colonoscopy in someone with bowel symptoms, and why follow-up after cancer treatment also includes scans and scopes rather than blood tests alone.
Common causes
Good health and not smoking
The usual reason for a low CEA. Non-smokers with no gut, lung or liver disease typically run under 2 ng/mL.
A cancer that does not produce CEA
About 25 percent of colorectal cancers and most early-stage ones are CEA-negative; a normal result in someone with symptoms is not reassuring on its own.
Successful treatment
After complete surgical removal CEA falls to normal within 4 to 6 weeks; chemotherapy that shrinks a tumor lowers it in proportion.
Stopping smoking
CEA drifts back toward non-smoker values over the months after quitting, which can make a previously borderline result normal.
Assay differences
Different manufacturers' tests read 10 to 20 percent apart, so a result that is normal at one lab may be borderline at another; monitoring should stay with one lab.
Symptoms that can go with it
- None; a normal CEA causes no symptoms
- Any ongoing bowel, weight or abdominal symptom still needs investigation, because CEA misses a substantial share of cancers
Read it alongside
- CA 19-9 — rises with pancreatic, bile duct and stomach cancers and with pancreatitis and bile duct obstruction; ordered alongside CEA when the upper abdomen is the concern.
- Hemoglobin and ferritin — unexplained iron-deficiency anemia in an adult, with or without a raised CEA, is a colonoscopy indication in its own right.
- ALT, AST, alkaline phosphatase and GGT — liver disease raises CEA by slowing its clearance; liver metastases raise alkaline phosphatase and GGT.
- TSH — hypothyroidism is an easily missed, easily fixed cause of a mildly raised CEA.
- CRP — helps show whether active inflammation (bowel, lung, pancreas) explains a modest rise.
- CA-125 and AFP — other tumor markers with the same limitation: useful for monitoring a known cancer, poor for screening.
- Calcitonin — measured with CEA when medullary thyroid cancer is suspected, since both rise in that condition.
What usually happens next
- A first raised CEA with no cancer diagnosis is repeated in 2 to 4 weeks, ideally at the same lab, with a review of smoking, lung, liver, bowel, pancreas and thyroid history; a single value is never acted on alone.
- If the repeat is still above the cut-off, and particularly if it is above 10 ng/mL or rising, expect a colonoscopy and a CT scan of the chest, abdomen and pelvis to look for a source.
- If you have had colorectal cancer, ask what your pre-surgery CEA was and what your post-surgery baseline is; guidelines suggest testing every 3 to 6 months for the first 2 to 3 years and then every 6 months to 5 years.
- A confirmed rise during follow-up (more than about 30 percent above baseline on two tests, or crossing the normal limit) is followed by CT or PET-CT, not by waiting for symptoms; recurrences found this way are more often operable.
- Keep using the same laboratory for serial measurements, because assay differences can mimic a change.
Diet, lifestyle and natural levers with evidence
What can move CEA once the cause is known. Nothing here replaces finding the cause.
Stop smoking
Strong evidenceSmoking is the single largest non-cancer influence on CEA. In the classic series of over 1,800 adults, smokers had roughly double the CEA of non-smokers and 19 percent exceeded 2.5 ng/mL compared with 3 percent of never-smokers; levels in former smokers sit between the two and fall toward never-smoker values over the years after quitting. Quitting also removes a major risk factor for the lung, pancreatic and colorectal cancers that CEA is used to follow.
Regular physical activity after colorectal cancer treatment
Moderate evidenceExercise does not lower CEA directly, but it changes the thing CEA is watching for. In the CALGB 89803 cohort of stage III colon cancer survivors, those doing the equivalent of 6 hours of brisk walking a week (18 or more MET-hours) had about half the risk of recurrence or death over 3 years compared with the least active, after adjusting for other factors. Observational data cannot prove cause, but the association has been consistent across cohorts.
Diet pattern after colorectal cancer
Moderate evidenceIn the same cohort, survivors eating the most Western-pattern diet (red and processed meat, refined grains, sugar, fat) had about three times the recurrence-or-death rate of those eating the least, while a prudent pattern of vegetables, fruit, fish and whole grains was not associated with harm. Higher fiber and whole-grain intake, and avoiding sugar-sweetened drinks, were linked to better survival in follow-up analyses. None of this changes a CEA reading on its own.
Treat the benign causes before re-testing
Moderate evidenceA mildly raised CEA often falls once the benign driver is handled: thyroid hormone replacement for hypothyroidism, control of a colitis flare, recovery from pancreatitis or pneumonia, and reduced drinking in alcoholic liver disease each bring CEA back toward normal over weeks. Re-testing 2 to 4 weeks after the condition settles avoids an unnecessary cancer work-up.
Do not treat a raised CEA as explained by a benign condition if it is above 10 ng/mL or still rising; those still need imaging and endoscopy.
When to see a clinician promptly
- A CEA above 10 ng/mL at any time, or above the normal range on two tests 2 to 4 weeks apart, with no established benign explanation.
- A rising CEA during follow-up after colorectal cancer treatment, even while you feel well; it needs imaging promptly, not at the next routine visit.
- Any raised CEA with rectal bleeding, black stools, a change in bowel habit lasting more than 3 weeks, unexplained weight loss or new iron-deficiency anemia.
- A raised CEA with jaundice, severe abdominal or back pain, persistent vomiting, or a new persistent cough or breathlessness.
- Severe abdominal pain with fever or inability to pass stool or gas, which can mean bowel obstruction or perforation and is an emergency regardless of the CEA.
Frequently asked questions
What is a normal CEA level?
Under 3 ng/mL for non-smokers and under 5 ng/mL for smokers is the usual convention, though labs vary and some use 2.5 or 5 ng/mL as a single cut-off. ng/mL and µg/L are the same number. Mild increases of a point or two with age and with chronic lung, liver or bowel conditions are common and do not by themselves mean cancer.
Is a CEA of 4, 6 or 8 high?
A CEA of 4 is normal for a smoker and only just above the non-smoker limit; 6 and 8 are mildly raised. In this 3 to 10 ng/mL band the most common causes are smoking, COPD, liver disease, pancreatitis, inflammatory bowel disease, diverticulitis and hypothyroidism, and cancer is the minority explanation. The usual plan is to repeat the test in 2 to 4 weeks and investigate if it stays up or climbs. Values above 10 are treated more seriously.
Can CEA be used to screen for cancer?
No. It misses most early colorectal cancers (only about a third raise it) and is raised by many non-cancer conditions, so it generates both false reassurance and false alarms. The American Society of Clinical Oncology and other guideline groups advise against using it to screen healthy people. Colonoscopy, stool-based tests and CT colonography are the screening tools; CEA is for monitoring a cancer already found.
What CEA level indicates metastasis?
There is no exact threshold, but in someone with a known colorectal cancer a CEA above 20 ng/mL is strongly associated with spread, most often to the liver, and values in the hundreds or thousands almost always reflect widespread disease. A pre-surgery CEA above 5 ng/mL carries a worse outlook at every stage. Some metastatic tumors, though, never raise CEA at all.
Why is CEA high in smokers?
Smoke irritates the lining of the airways and gut, and the cells there respond by making more CEA; smoking also causes chronic lung disease, which raises it further. Smokers run levels roughly twice those of non-smokers and about 1 in 5 exceeds the non-smoker limit. Labs allow for this with a separate cut-off of 5 ng/mL, and levels fall gradually after quitting.
How often is CEA checked after colon cancer surgery?
Most guidelines recommend a CEA every 3 to 6 months for the first 2 to 3 years, then every 6 months until 5 years, alongside scheduled CT scans and colonoscopy. A level that rises by about 30 percent above your baseline on two consecutive tests, or climbs above the normal range, prompts imaging. The same laboratory should be used throughout.
How long does it take CEA to go down after surgery?
CEA has a half-life of a few days, so after a tumor is completely removed it typically returns to the normal range within 4 to 6 weeks. The first post-operative value is usually taken around 6 weeks for that reason. A level that stays high after that point suggests cancer remains, either at the original site or elsewhere, and is investigated.
Do I need to fast for a CEA test?
No. CEA is not affected by food or by the time of day. Tell the lab or your clinician if you smoke, and mention recent infections, a bowel disease flare, pancreatitis, liver disease or an underactive thyroid, since any of these can nudge the result up and change how it is read.
References
- CEA test. MedlinePlus, US National Library of Medicine (2023)View source
- Tumor markers in common use. National Cancer Institute (2024)View source
- Locker GY, Hamilton S, Harris J, et al.. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. Journal of Clinical Oncology (2006)
- Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?. Clinical Chemistry (2001)
- Alexander JC, Silverman NA, Chretien PB. Effect of age and cigarette smoking on carcinoembryonic antigen levels. JAMA (1976)
- Thirunavukarasu P, Sukumar S, Sathaiah M, et al.. C-stage in colon cancer: implications of carcinoembryonic antigen biomarker in staging, prognosis, and management. Journal of the National Cancer Institute (2011)
- Fletcher RH. Carcinoembryonic antigen. Annals of Internal Medicine (1986)
- Meyerhardt JA, Heseltine D, Niedzwiecki D, et al.. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. Journal of Clinical Oncology (2006)
- Meyerhardt JA, Niedzwiecki D, Hollis D, et al.. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA (2007)
- Hammarström S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Seminars in Cancer Biology (1999)
- Colorectal cancer. Merck Manual Professional Version (2024)
Related markers
Related conditions
Evidence guides
Worried about your number?
Ask AskMN what your CEA result could mean in the context of your other results, symptoms and medications. Free, unlimited, no account needed.
Ask about my CEAThis page is educational and is not medical advice or a diagnosis. Lab results have to be interpreted together with your history, symptoms and other results by a clinician who knows you. Do not start or stop a supplement to change a lab value before the cause is known.